Metabolic derangements in COPD muscle dysfunction

Journal of Applied Physiology

Volumn 114, Issue 9, 2013, Pages 1282-1290

  Puente Maestu, Luis ^a   Lázaro, Alberto ^a   Humanes, Blanca ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Bioenergetics; Electron transport chain; Magnetic resonance spectroscopy; Mitochondria; Oxidative enzymes; Permeability transition pore; Reactive oxygen species

Indexed keywords

CARRIER PROTEIN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; REACTIVE OXYGEN METABOLITE;

BIOENERGY; BIOLOGICAL MODEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; METABOLISM; MITOCHONDRION; MUSCLE MITOCHONDRION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE ENZYMES; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PERMEABILITY TRANSITION PORE; RESPIRATORY CHAIN; REVIEW; SKELETAL MUSCLE;

BIOENERGETICS; ELECTRON TRANSPORT CHAIN; MAGNETIC RESONANCE SPECTROSCOPY; MITOCHONDRIA; OXIDATIVE ENZYMES; PERMEABILITY TRANSITION PORE; REACTIVE OXYGEN SPECIES;

HUMANS; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REACTIVE OXYGEN SPECIES;

EID: 84878552818     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00815.2012     Document Type: Review

References (112)

1. Agusti AG, Sauleda J, Miralles C, Gomez C, Togores B, Sala E, Batle S, Busquets X. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166:485-489, 2002.
2. Allaire J, Maltais F, Doyon JF, Noel M, Le Blanc P, Carrier G, Simard C, Jobin J. Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax 59:673-678, 2004. (Pubitemid 39061530)
3. [Anon]. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 159:S1-S40, 1999.
4. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 33:1165-1185, 2009.
5. Barreiro E, De La Puente B, Minguella J, Corominas JM, Serrano S, Hussain SN, Gea J. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171:1116-1124, 2005. (Pubitemid 40663723)
6. Barreiro E, Ferrer D, Sanchez F, Minguella J, Marin-Corral J, Martinez-Llorens J, Lloreta J, Gea J. Inflammatory cells and apoptosis in respiratory and limb muscles of patients with COPD. J Appl Physiol 111:808-817, 2011.
7. Barreiro E, Gea J, Corominas JM, Hussain SN. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 29:771-778, 2003. (Pubitemid 38045945)
8. Barreiro E, Gea J, Matar G, Hussain SN. Expression and carbonylation of creatine kinase in the quadriceps femoris muscles of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 33:636-642, 2005. (Pubitemid 41753140)
9. Borghi-Silva A, Oliveira CC, Carrascosa C, Maia J, Berton DC, Queiroga F Jr, Ferreira EM, Almeida DR, Nery LE, Neder JA. Respiratory muscle unloading improves leg muscle oxygenation during exercise in patients with COPD. Thorax 63:910-915, 2008.
10. Bronstad E, Rognmo O, Tjonna AE, Dedichen HH, Kirkeby-Garstad I, Haberg AK, Bjork IC, Wisloff U, Steinshamn S. High-intensity knee extensor training restores skeletal muscle function in COPD patients. Eur Respir J 40:1130-1136, 2012.
11. Campbell JA, Hughes RL, Sahgal V, Frederiksen J, Shields TW. Alterations in intercostal muscle morphology and biochemistry in patients with obstructive lung disease. Am Rev Respir Dis 122:679-686, 1980. (Pubitemid 11194214)
12. Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner CF, Wasserman K. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 143:9-18, 1991.
13. Couillard A, Koechlin C, Cristol JP, Varray A, Prefaut C. Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients. Eur Respir J 20:1123-1129, 2002. (Pubitemid 35331868)
14. Couillard A, Maltais F, Saey D, Debigare R, Michaud A, Koechlin C, Le Blanc P, Prefaut C. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167:1664-1669, 2003. (Pubitemid 36760681)
15. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341:233-249, 1999. (Pubitemid 29373645)
16. Dean RT, Fu S, Stocker R, Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 324:1-18, 1997. (Pubitemid 27229359)
17. Den HM, Hesselink MK, Van Kranenburg GP, Westerterp KR. Habitual physical activity in daily life correlates positively with markers for mitochondrial capacity. J Appl Physiol 105:561-568, 2008.
18. Doucet M, Debigare R, Joanisse DR, Cote C, Le Blanc P, Gregoire J, Deslauriers J, Vaillancourt R, Maltais F. Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD. Eur Respir J 24:971-979, 2004. (Pubitemid 39642288)
19. Engelen MP, Casaburi R, Rucker R, Carithers E. Contribution of the respiratory muscles to the lactic acidosis of heavy exercise in COPD. Chest 108:1246-1251, 1995.
20. Engelen MP, Orozco-Levi M, Deutz NE, Barreiro E, Hernandez N, Wouters EF, Gea J, Schols AM. Glutathione and glutamate levels in the diaphragm of patients with chronic obstructive pulmonary disease. Eur Respir J 23:545-551, 2004. (Pubitemid 38455995)
21. Engelen MP, Schols AM, Does JD, Deutz NE, Wouters EF. Altered glutamate metabolism is associated with reduced muscle glutathione levels in patients with emphysema. Am J Respir Crit Care Med 161:98-103, 2000. (Pubitemid 30055909)
22. Engelen MP, Wouters EF, Deutz NE, Does JD, Schols AM. Effects of exercise on amino acid metabolism in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163:859-864, 2001. (Pubitemid 32275855)
23. Engelen MP, Wouters EF, Deutz NE, Menheere PP, Schols AM. Factors contributing to alterations in skeletal muscle and plasma amino acid profiles in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 72:1480-1487, 2000.
24. Gea JG. Myosin gene expression in the respiratory muscles. Eur Respir J 10:2404-2410, 1997. (Pubitemid 27479568)
25. Gnaiger E, Lassnig B, Kuznetsov A, Rieger G, Margreiter R. Mitochondrial oxygen affinity, respiratory flux control and excess capacity of cytochrome c oxidase. J Exp Biol 201:1129-1139, 1998. (Pubitemid 28278318)
26. Gollnick PD. Peripheral factors as limitations to exercise capacity. Can J Appl Sport Sci 7:14-21, 1982.
27. Gosker HR, Bast A, Haenen GR, Fischer MA, Van Der Vusse GJ, Wouters EF, Schols AM. Altered antioxidant status in peripheral skeletal muscle of patients with COPD. Respir Med 99:118-125, 2005. (Pubitemid 40017395)
28. Gosker HR, Hesselink MK, Duimel H, Ward KA, Schols AM. Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD. Eur Respir J 30:73-79, 2007. (Pubitemid 47074009)
29. Gosker HR, Schrauwen P, Hesselink MK, Schaart G, Van Der Vusse GJ, Wouters EF, Schols AM. Uncoupling protein-3 content is decreased in peripheral skeletal muscle of patients with COPD. Eur Respir J 22:88-93, 2003. (Pubitemid 36896476)
30. Gosker HR, Wouters EF, Van Der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 71:1033-1047, 2000. (Pubitemid 30230549)
31. Gosker HR, Zeegers MP, Wouters EF, Schols AM. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax 62:944-949, 2007. (Pubitemid 350084491)
32. 2+-sequestering properties in skeletal muscle in chronic obstructive pulmonary disease. Am J Physiol Cell Physiol 295:C350-C357, 2008. (Pubitemid 352755763)
33. Green HJ, Burnett ME, D'Arsigny CL, O'Donnell DE, Ouyang J, Webb KA. Altered metabolic and transporter characteristics of vastus lateralis in chronic obstructive pulmonary disease. J Appl Physiol 105:879-886, 2008.
34. Guzy RD, Schumacker PT. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol 91:807-819, 2006. (Pubitemid 44266577)
35. Hamaoka T, Tatsumi K, Saito Y, Arai Y, Horie Y, Masuyama S, Tanabe N, Takiguchi Y, Ikehira H, Obata T, Sasaki Y, Tanada S, Kuriyama T. Metabolic activity in skeletal muscles of patients with non-hypoxaemic chronic obstructive pulmonary disease studied by 31Pmagnetic resonance spectroscopy. Respirology 10:164-170, 2005. (Pubitemid 40637999)
36. Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS Jr. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325:147-152, 1991.
37. Henze K, Martin W. Evolutionary biology: essence of mitochondria. Nature 426:127-128, 2003.
38. Heunks LM, Vina J, Van Herwaarden CL, Folgering HT, Gimeno A, Dekhuijzen PN. Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Physiol Regul Integr Comp Physiol 277:R1697-R1704, 1999. (Pubitemid 30043777)
39. Honda HM, Ping P. Mitochondrial permeability transition in cardiac cell injury and death. Cardiovasc Drugs Ther 20:425-432, 2006. (Pubitemid 46144219)
40. Hoppeler H, Weibel ER. Limits for oxygen and substrate transport in mammals. J Exp Biol 201:1051-1064, 1998. (Pubitemid 28278312)
41. Hughes RL, Katz H, Sahgal V, Campbell JA, Hartz R, Shields TW. Fiber size and energy metabolites in five separate muscles from patients with chronic obstructive lung diseases. Respiration 44:321-328, 1983. (Pubitemid 13041765)
42. Jackman MR, Willis WT. Characteristics of mitochondria isolated from type I and type IIb skeletal muscle. Am J Physiol Cell Physiol 270:C673-C678, 1996.
43. Jakobsson P, Jorfeldt L, Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 151:374-377, 1995.
44. Ji LL. Exercise, oxidative stress, antioxidants. Am J Sports Med 24:S20-S24, 1996.
45. Ji LL. Modulation of skeletal muscle antioxidant defense by exercise: role of redox signaling. Free Radic Biol Med 44:142-152, 2008.
46. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51:2944-2950, 2002.
47. Korshunov SS, Skulachev VP, Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 416:15-18, 1997. (Pubitemid 27470791)
48. Kutsuzawa T, Shioya S, Kurita D, Haida M. Plasma branched-chain amino acid levels and muscle energy metabolism in patients with chronic obstructive pulmonary disease. Clin Nutr 28:203-208, 2009.
49. Laveneziana P, Palange P. Physical activity, nutritional status and systemic inflammation in COPD. Eur Respir J 40:522-529, 2012.
50. Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL. Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging, and heart failure. J Mol Cell Cardiol 33:1065-1089, 2001. (Pubitemid 32579276)
51. Levine S, Gregory C, Nguyen T, Shrager J, Kaiser L, Rubinstein N, Dudley G. Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD. J Appl Physiol 92:1205-1213, 2002. (Pubitemid 34670981)
52. Levine S, Kaiser L, Leferovich J, Tikunov B. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 337:1799-1806, 1997. (Pubitemid 28006784)
53. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, Spiegelman BM. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418:797-801, 2002.
54. Lira VA, Benton CR, Yan Z, Bonen A. PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity. Am J Physiol Endocrinol Metab 299:E145-E161, 2010.
55. Mador MJ, Deniz O, Aggarwal A, Kufel TJ. Quadriceps fatigability after single muscle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 168:102-108, 2003. (Pubitemid 37046639)
56. Maltais F, Le Blanc P, Simard C, Jobin J, Berube C, Bruneau J, Carrier L, Belleau R. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154:442-447, 1996. (Pubitemid 26269117)
57. Maltais F, Le Blanc P, Whittom F, Simard C, Marquis K, Belanger M, Breton MJ, Jobin J. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 55:848-853, 2000.
58. Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, Le Blanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 153:288-293, 1996. (Pubitemid 26026864)
59. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 32:962-969, 2008.
60. Marin-Corral J, Minguella J, Ramirez-Sarmiento AL, Hussain SN, Gea J, Barreiro E. Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients. Eur Respir J 33:1309-1319, 2009.
61. Mathur R, Cox IJ, Oatridge A, Shephard DT, Shaw RJ, Taylor-Robinson SD. Cerebral bioenergetics in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160:1994-1999, 1999. (Pubitemid 30004709)
62. McBride HM, Neuspiel M, Wasiak S. Mitochondria: more than just a powerhouse. Curr Biol 16:R551-R560, 2006. (Pubitemid 44066793)
63. McCully KK, Fielding RA, Evans WJ, Leigh JS Jr, Posner JD. Relationships between in vivo and in vitro measurements of metabolism in young and old human calf muscles. J Appl Physiol 75:813-819, 1993. (Pubitemid 23260225)
64. McKeough ZJ, Alison JA, Bye PT, Trenell MI, Sachinwalla T, Thompson CH, Kemp GJ. Exercise capacity and quadriceps muscle metabolism following training in subjects with COPD. Respir Med 100:1817-1825, 2006. (Pubitemid 44375488)
65. Meyer RA, Kuchmerick MJ, Brown TR. Application of 31P-NMR spectroscopy to the study of striated muscle metabolism. Am J Physiol Cell Physiol 242:C1-C11, 1982. (Pubitemid 12098491)
66. Mizuno M. Human respiratory muscles: fibre morphology and capillary supply. Eur Respir J 4:587-601, 1991.
67. Montes De Oca M, Loeb E, Torres SH, De Sanctis J, Hernandez N, Talamo C. Peripheral muscle alterations in non-COPD smokers. Chest 133:13-18, 2008.
68. Morla M, Iglesias A, Sauleda J, Cosio B, Agusti A, Busquets X. [Reduced expression of the sarcoplasmic calcium pump SERCA2 in skeletal muscle from patients with chronic obstructive pulmonary disease and low body weight]. Arch Bronconeumol 43:4-8, 2007. (Pubitemid 46232750)
69. Nagasawa T, Hatayama T, Watanabe Y, Tanaka M, Niisato Y, Kitts DD. Free radical-mediated effects on skeletal muscle protein in rats treated with Fe-nitrilotriacetate. Biochem Biophys Res Commun 231:37-41, 1997. (Pubitemid 27212105)
70. Naimi AI, Bourbeau J, Perrault H, Baril J, Wright-Paradis C, Rossi A, Taivassalo T, Sheel AW, Rabol R, Dela F, Boushel R. Altered mitochondrial regulation in quadriceps muscles of patients with COPD. Clin Physiol Funct Imaging 31:124-131, 2011.
71. Nguyen T, Rubinstein NA, Vijayasarathy C, Rome LC, Kaiser LR, Shrager JB, Levine S. Effect of chronic obstructive pulmonary disease on calcium pump ATPase expression in human diaphragm. J Appl Physiol 98:2004-2010, 2005. (Pubitemid 40726890)
72. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315-424, 2007. (Pubitemid 46217686)
73. Panos RJ, Eschenbacher W. Exertional desaturation in patients with chronic obstructive pulmonary disease. COPD 6:478-487, 2009.
74. Pasto M, Gea J, Blanco M, Orozco-Levi M, Pallas O, Masdeu M, Broquetas J. [Metabolic activity of the external intercostal muscle of patients with COPD]. Arch Bronconeumol 37:108-114, 2001. (Pubitemid 33682784)
75. Patti ME, Corvera S. The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev 31:364-395, 2010.
76. Payen JF, Wuyam B, Levy P, Reutenauer H, Stieglitz P, Paramelle B, Le Bas JF. Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia. Am Rev Respir Dis 147:592-598, 1993. (Pubitemid 23072647)
77. Picard M, Godin R, Sinnreich M, Baril J, Bourbeau J, Perrault H, Taivassalo T, Burelle Y. The mitochondrial phenotype of peripheral muscle in chronic obstructive pulmonary disease: disuse or dysfunction? Am J Respir Crit Care Med 178:1040-1047, 2008.
78. Picard M, Hepple RT, Burelle Y. Mitochondrial functional specialization in glycolytic and oxidative muscle fibers: tailoring the organelle for optimal function. Am J Physiol Cell Physiol 302:C629-C641, 2012.
79. Pinho RA, Chiesa D, Mezzomo KM, Andrades ME, Bonatto F, Gelain D, Dal PF, Knorst MM, Moreira JC. Oxidative stress in chronic obstructive pulmonary disease patients submitted to a rehabilitation program. Respir Med 101:1830-1835, 2007. (Pubitemid 46957333)
80. Pouw EM, Schols AM, Van Der Vusse GJ, Wouters EF. Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:453-457, 1998. (Pubitemid 28090534)
81. Powers SK, Jackson MJ. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev 88:1243-1276, 2008.
82. Puente-Maestu L, Garcia De Pedro J, Martinez-Abad Y, Ruiz De Ona JM, Llorente D, Cubillo JM. Dyspnea, ventilatory pattern, and changes in dynamic hyperinflation related to the intensity of constant work rate exercise in COPD. Chest 128:651-656, 2005. (Pubitemid 41140492)
83. Puente-Maestu L, Lazaro A, Tejedor A, Camano S, Fuentes M, Cuervo M, Navarro BO, Agusti A. Effects of exercise on mitochondrial DNA content in skeletal muscle of patients with COPD. Thorax 66:121-127, 2011.
84. Puente-Maestu L, Perez-Parra J, Godoy R, Moreno N, Tejedor A, Gonzalez-Aragoneses F, Bravo JL, Alvarez FV, Camano S, Agusti A. Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients. Eur Respir J 33:1045-1052, 2009.
85. Puente-Maestu L, Perez-Parra J, Godoy R, Moreno N, Tejedor A, Torres A, Lazaro A, Ferreira A, Agusti A. Abnormal transition pore kinetics and cytochrome C release in muscle mitochondria of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 40:746-750, 2009.
86. Puente-Maestu L, Sanz ML, Sanz P, Ruiz De Ona JM, Rodriguez-Hermosa JL, Whipp BJ. Effects of two types of training on pulmonary and cardiac responses to moderate exercise in patients with COPD. Eur Respir J 15:1026-1032, 2000. (Pubitemid 30399271)
87. Puente-Maestu L, Tejedor A, Lazaro A, De Miguel J, Alvarez-Sala L, Gonzalez-Aragoneses F, Simon C, Agusti A. Site of mitochondrial ROS production in skeletal muscle of COPD and its relationship with exercise oxidative stress. Am J Respir Cell Mol Biol 47:358-362, 2012.
88. Puente-Maestu L, Tena T, Trascasa C, Perez-Parra J, Godoy R, Garcia MJ, Stringer WW. Training improves muscle oxidative capacity and oxygenation recovery kinetics in patients with chronic obstructive pulmonary disease. Eur J Appl Physiol 88:580-587, 2003. (Pubitemid 36748734)
89. Rabinovich RA, Ardite E, Mayer AM, Polo MF, Vilaro J, Argiles JM, Roca J. Training depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index. Respiration 73:757-761, 2006. (Pubitemid 44795921)
90. Rabinovich RA, Ardite E, Troosters T, Carbo N, Alonso J, Gonzalez De Suso JM, Vilaro J, Barbera JA, Polo MF, Argiles JM, Fernandez-Checa JC, Roca J. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164:1114-1118, 2001. (Pubitemid 33052236)
91. Rabinovich RA, Bastos R, Ardite E, Llinas L, Orozco-Levi M, Gea J, Vilaro J, Barbera JA, Rodriguez-Roisin R, Fernandez-Checa JC, Roca J. Mitochondrial dysfunction in COPD patients with low body mass index. Eur Respir J 29:643-650, 2007. (Pubitemid 46554612)
92. Radom-Aizik S, Kaminski N, Hayek S, Halkin H, Cooper DM, Ben-Dov I. Effects of exercise training on quadriceps muscle gene expression in chronic obstructive pulmonary disease. J Appl Physiol 102:1976-1984, 2007. (Pubitemid 46701970)
93. Remels AH, Gosker HR, Schrauwen P, Hommelberg PP, Sliwinski P, Polkey M, Galdiz J, Wouters EF, Langen RC, Schols AM. TNF-alpha impairs regulation of muscle oxidative phenotype: implications for cachexia? FASEB J 24:5052-5062, 2010.
94. Remels AH, Schrauwen P, Broekhuizen R, Willems J, Kersten S, Gosker HR, Schols AM. Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD. Eur Respir J 30:245-252, 2007. (Pubitemid 47194177)
95. Ribera F, N'Guessan B, Zoll J, Fortin D, Serrurier B, Mettauer B, Bigard X, Ventura-Clapier R, Lampert E. Mitochondrial electron transport chain function is enhanced in inspiratory muscles of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167:873-879, 2003. (Pubitemid 36801776)
96. 2 max in the exercisetrained human quadriceps. J Appl Physiol 86:1048-1053, 1999. (Pubitemid 29118030)
97. 2 with small muscle mass exercise. Am J Respir Crit Care Med 169:89-96, 2004. (Pubitemid 38233894)
98. Rodriguez DA, Kalko S, Puig-Vilanova E, Perez-Olabarria M, Falciani F, Gea J, Cascante M, Barreiro E, Roca J. Muscle and blood redox status after exercise training in severe COPD patients. Free Radic Biol Med 52:88-94, 2012.
99. Sala E, Roca J, Marrades RM, Alonso J, Gonzalez De Suso JM, Moreno A, Barbera JA, Nadal J, De Jover L, Rodriguez-Roisin R, Wagner PD. Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159:1726-1734, 1999. (Pubitemid 29275034)
100. Sanchez J, Bastien C, Medrano G, Riquet M, Derenne JP. Metabolic enzymatic activities in the diaphragm of normal men and patients with moderate chronic obstructive pulmonary disease. Bull Eur Physiopath Respir 20:535-540, 1984. (Pubitemid 15221462)
101. Sanchez J, Brunet A, Medrano G, Debesse B, Derenne JP. Metabolic enzymatic activities in the intercostal and serratus muscles and in the latissimus dorsi of middle-aged normal men and patients with moderate obstructive pulmonary disease. Eur Respir J 1:376-383, 1988.
102. Sauleda J, Garcia-Palmer F, Wiesner RJ, Tarraga S, Harting I, Tomas P, Gomez C, Saus C, Palou A, Agusti AG. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:1413-1417, 1998.
103. Sauleda J, Garcia-Palmer FJ, Palou A, Agusti AG. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152:1137-1138, 1995.
104. Schwerzmann K, Hoppeler H, Kayar SR, Weibel ER. Oxidative capacity of muscle and mitochondria: correlation of physiological, biochemical, and morphometric characteristics. Proc Natl Acad Sci U S A 86:1583-1587, 1989. (Pubitemid 19078947)
105. Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC) - Potsdam Study. Diabetes 52:812-817, 2003. (Pubitemid 36323590)
106. 2 production by membrane potential and NAD (P) H redox state. J Neurochem 86:1101-1107, 2003. (Pubitemid 37022186)
107. Tada H, Kato H, Misawa T, Sasaki F, Hayashi S, Takahashi H, Kutsumi Y, Ishizaki T, Nakai T, Miyabo S. 31P-nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with chronic lung disease and congestive heart failure. Eur Respir J 5:163-169, 1992.
108. Tonkonogi M, Walsh B, Svensson M, Sahlin K. Mitochondrial function and antioxidative defence in human muscle: effects of endurance training and oxidative stress. J Physiol 528:379-388, 2000.
109. Wagner PD. Determinants of maximal oxygen transport and utilization. Annu Rev Physiol 58:21-50, 1996. (Pubitemid 26106712)
110. Wijnhoven JH, Janssen AJ, Van Kuppevelt TH, Rodenburg RJ, Dekhuijzen PN. Metabolic capacity of the diaphragm in patients with COPD. Respir Med 100:1064-1071, 2006.
111. Wust RC, Degens H. Factors contributing to muscle wasting and dysfunction in COPD patients. Int J Chron Obstruct Pulmon Dis 2:289-300, 2007. (Pubitemid 350110902)
112. Wuyam B, Payen JF, Levy P, Bensaidane H, Reutenauer H, Le Bas JF, Benabid AL. Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease. Eur Respir J 5:157-162, 1992.